Fidaxomicin is a novel macrolide antibiotic used in the treatment of diarrhea caused by Clostridioides (formerly Clostridium) difficile in adult and pediatric patients over the age of 6 months. Fidaxomicin is a naturally-occurring 18-member macrocycle derived from fermentation. Because fidaxomicin contains an 18-membered lactone ring in its structure, it is ...
用于治疗艰难梭菌(又名难辨梭状芽孢杆菌)感染相关性腹泻。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.